These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7108382)

  • 1. [Physicochemical study of ticlopidine absorption kinetics on human platelet membrane (author's transl)].
    Stoltz JF; Solagna S; Verry M; Nicolas A; Donner M
    J Mal Vasc; 1982; 7(2):125-8. PubMed ID: 7108382
    [No Abstract]   [Full Text] [Related]  

  • 2. Spin label study of the effect of ticlopidine on platelets.
    Hongo T; Setaka M; Kwan T
    Jpn J Pharmacol; 1985 Sep; 39(1):59-66. PubMed ID: 2999489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Migraine or transient ischemic attacks in a patient with essential thrombocythaemia. Treatment with ticlopidine (author's transl)].
    Bousser MG; Conard J; Lecrubier C; Bousser J
    Ann Med Interne (Paris); 1980; 131(2):87-90. PubMed ID: 7396326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concerning the problem of availability of platelet factor 3 and of acid phosphatases (author's transl)].
    Kubisz P
    Bratisl Lek Listy; 1974; 62(1):42-7. PubMed ID: 4848364
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of oral ticlopidine on arachidonic acid products in human platelets.
    Bruno JJ; Chang LF; McSpadden MM; Yang D
    Agents Actions Suppl; 1984; 15():76-87. PubMed ID: 6435408
    [No Abstract]   [Full Text] [Related]  

  • 6. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
    Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
    Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombocytopenia due to antibodies induced by ticlopidine].
    Claas FH; de Fraiture WH; Meyboom RH
    Nouv Rev Fr Hematol (1978); 1984; 26(5):323-4. PubMed ID: 6504695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet membrane fluidity in Alzheimer's disease and major depression.
    Zubenko GS; Cohen BM; Reynolds CF; Boller F; Malinakova I; Keefe N
    Am J Psychiatry; 1987 Jul; 144(7):860-8. PubMed ID: 3605398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biosynthesis of prostaglandin with special reference to their endoperoxides (author's transl)].
    Yamamoto T; Miyamoto T
    Tanpakushitsu Kakusan Koso; 1976 Mar; 21(3):174-83. PubMed ID: 819966
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of ticlopidine on blood circulation and thrombin-induced platelet aggregation in experimental diabetic rats- and it's efficacy for remedy of diabetic retinopathy (author's transl)].
    Fujie K; Fujie Y
    Nippon Ganka Gakkai Zasshi; 1981 Mar; 85(3):242-9. PubMed ID: 7270347
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hematological toxicity of ticlopidine? (author's transl)].
    de Gramont A; Canuel C; Krulik M; Bauters F; Degos L; Marty M; Najean Y
    Nouv Rev Fr Hematol (1978); 1982; 24(1):35-7. PubMed ID: 7071010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Membrane glycoproteins (author's transl)].
    Kawasaki T; Yamashina I
    Tanpakushitsu Kakusan Koso; 1974 Jan; 19(1):17-26. PubMed ID: 4274278
    [No Abstract]   [Full Text] [Related]  

  • 14. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
    Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
    J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
    Lee H; Paton RC; Ruan C; Caen JP
    Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite.
    Sugidachi A; Ogawa T; Kurihara A; Hagihara K; Jakubowski JA; Hashimoto M; Niitsu Y; Asai F
    J Thromb Haemost; 2007 Jul; 5(7):1545-51. PubMed ID: 17456192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on platelet kinetics by determination of malondialdehyde after aspirin-ingestion (author's transl)].
    Arai H
    Rinsho Byori; 1980 Oct; 28(10):989-93. PubMed ID: 7253282
    [No Abstract]   [Full Text] [Related]  

  • 18. Can flow cytometry detect successful ticlopidine treatment in patients with VVI pacemakers?
    Koşar F; Durmaz T; Hisar I; Ayaz S; Saşmaz H; Korkmaz S; Saşmaz A
    J Invasive Cardiol; 1999 Aug; 11(8):471-4. PubMed ID: 10745577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ticarcillin: in-vitro activity and pharmacokinetics (author's transl)].
    Simon C; Leuth M; Malerczyk V
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2460-4. PubMed ID: 4218163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of platelet aggregation inhibition].
    Abiko Y; Ashida S
    Rinsho Byori; 1979; Suppl 40():169-80. PubMed ID: 233105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.